Simon Robinson

Simon Robinson is a seasoned pharmaceutical and research executive with extensive experience in the fields of cancer and cardiovascular imaging. As Vice President of Research and Pharmaceutical Development at Lantheus Medical Imaging since 2008, Simon has led discovery research and development strategies, notably for Flurpiridaz F18, and co-chairs a key healthcare committee. Previous roles include Senior Director at Lantheus, where Simon directed discovery chemistry and biology teams, as well as positions at BMS, Du Pont Pharma, BASF, Sphinx Pharmaceutical Company, and Bristol-Myers Squibb, spanning over three decades of leadership in oncology pharmacology, research strategy development, and regulatory consultations. Simon holds a PhD and BSc in Pharmacology from the University of Leeds.